ArticleLeukemia1999

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.

M J Pongers-Willemse et al.PubMed ↗Publisher ↗

No numbers read from the abstract.